References
- LindbladEBAluminium compounds for use in vaccinesImmunol Cell Biol200482549750515479435
- HogeneschHMechanism of immunopotentiation and safety of aluminum adjuvantsFront Immunol2013340623335921
- TalbotRJNewtonDPriestNDAustinJGDayJPInter-subject variability in the metabolism of aluminium following intravenous injection as citrateHum Exp Toxicol19951475955997576820
- MinshallCNadalJExleyCAluminium in human sweatJ Trace Elem Med Biol2014281878824239230
- LiPLuoZLiuPBioreducible alginate-poly (ethylenimine) nanogels asan antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responsesJ Control Release2013168127127923562637
- DémoulinsTBassiIThomann-HarwoodLAlginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cellsNanomedicine20139680681723347894
- KangKHKimCHInhibitory effect of Rehmannia glutinosa pharmacopuncture solution on β-hexosaminidase release and cytokine production via immunoglobulin receptor signaling in RBL-2H3 cellsJ Acupunct Meridian Stud201144269
- HuangYJiangCHuYImmunoenhancement effect of Rehmannia glutinosa polysaccharide on lymphocyte proliferation and dendritic cellCarbohydr Polym201396251652123768595
- GregoryAETitballRWilliamsonDVaccine delivery using nanoparticlesFront Cell Infect Microbiol201331323532930
- ZhaoLSethAWibowoNNanoparticle vaccinesVaccine201432332733724295808
- DobrovolskaiaMAMcNeilSEImmunological properties of engineered nanomaterialsNat Nanotechnol2007246947818654343
- RoldaoAMelladoMCCastilhoLRCarrondoMJAlvesPMVirus-like particles in vaccine developmentExpert Rev Vaccines20109101149117620923267
- PatilHPMurugappanSter VeerWEvaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccineJ Control Release2014174516224269505
- KlibanovALShevchenkoTIRajuBISeipRChinCTUltrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug deliveryJ Control Release20101481131720691227
- WatsonaDSEndsleyANHuangLDesign considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensVaccine201230132256227222306376
- SchwendenerRALiposomes as vaccine delivery systems: a review of the recent advancesTher Adv Vaccines20142615918225364509
- HuangYWuCLiuZOptimization on preparation conditions of Rehmannia glutinosa polysaccharide liposome and its immunology activityCarbohydr Polym201410411812624607168
- HuangYLiuZBoRThe enhanced immune response of PCV-2 vaccine using Rehmannia glutinosa polysaccharide liposome as an adjuvantInt J Biol Macromol20168692993626851361
- ZhaoXJLuYTaoYSalidroside liposome formulation enhances the activity of dendritic cells and immune responsesInt Immunopharmacol20131741134114024188805
- DengWFuMCaoYAngelica sinensis polysaccharide nanoparticles as novel non-viral carriers for gene delivery to mesenchymal stem cellsNanomedicine20139811811191
- BronteVPittetMJThe spleen in local and systemic regulation of immunityImmunity201339580681824238338
- PanWHLiuXYWangYPEffects of ginsenoside on immunocompetence of mice splenic lymphocyte and peritoneal macrophageRes On Spec Local Products200111619
- ElserBLohoffMKockSIFN-γ represses IL-4 expression via IRF-1 and IRF-2Immunity200217670371212479817
- NakamuraTKamogawaYBottomlyKFlavellRAPolarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naïve CD4+ T cellsJ Immunol19971583108510949013946
- SallustoFGeginatJLanzavecchiaACentral memory and effector memory T cell subsets: function, generation, and maintenanceAnnu Rev Immunol20042274576315032595
- XiangSDScholzenAMinigoGPathogen recognition and development of particulate vaccines: does size matter?Methods20064011916997708
- PatiRMehtaRKMohantySTopical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophagesNanomedicine20141061195120824607937
- CoimbraMBanciuMFensMHLiposomal pravastatin inhibits tumor growth by targeting cancer-related inflammationJ Control Release2010148330331020869410
- OrrMTFoxCBBaldwinSLAdjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosisJ Control Release2013172119020023933525
- BadieeAKhamesipourASamieiAThe role of liposome size on the type of immune response induced in C57BL/6J mice against leishmaniasis: rgp63 as a model antigenExp Parasitol2012132440340922982807
- PulendranBAhmedRTranslating innate immunity into immunological memory: implications for vaccine developmentCell2006124484986316497593
- PlantingaMGuilliamsMVanheerswynghelsMConventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergenImmunity201338232233523352232
- PowellNDMaysJWBaileyMTHankeMLSheridanJFImmunogenic dendritic cells primed by social defeat enhance adaptive immunity to influenza A virusBrain Behav Immun2011252011465220656014
- MellmanISteinmanRMDendritic cells: specialized and regulated antigen processing machinesCell2001106325525811509172
- MeliefCJMini-review: regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct primingEur J Immunol200333102645265414515248